Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016475
Filing Date
2025-05-13
Accepted
2025-05-13 16:21:11
Documents
64
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eton20250331_10q.htm   iXBRL 10-Q 858541
2 EXHIBIT 31.1 ex_763231.htm EX-31.1 8795
3 EXHIBIT 31.2 ex_763232.htm EX-31.2 8795
4 EXHIBIT 32.1 ex_763233.htm EX-32.1 6328
  Complete submission text file 0001437749-25-016475.txt   5624917

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eton-20250331.xsd EX-101.SCH 53635
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eton-20250331_cal.xml EX-101.CAL 33340
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20250331_def.xml EX-101.DEF 425891
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20250331_lab.xml EX-101.LAB 361733
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20250331_pre.xml EX-101.PRE 448990
67 EXTRACTED XBRL INSTANCE DOCUMENT eton20250331_10q_htm.xml XML 666836
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 25940464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)